Latest filing published 16 Mar 2026 for Surgery Partners, Inc., €97k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David T. Doherty (finance chief) discloses dealings in Surgery Partners, Inc. to SEC (Form 4). The record holds 34 filings, for trades running from 1 February 2022 to 16 March 2026.
On the market, this insider has only sold: 23 sales, €3.3M in total. Other entries cover 11 share grants. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 16 March 2026, reports an open-market sale of €97k in Surgery Partners, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations